Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
AstraZeneca
US Army
Teva
Colorcon
Merck

Generated: May 21, 2019

DrugPatentWatch Database Preview

Drug Price Trends for SUMATRIPTAN-NAPROXEN

« Back to Dashboard

Drug Price Trends for SUMATRIPTAN-NAPROXEN

Average Pharmacy Cost for SUMATRIPTAN-NAPROXEN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
SUMATRIPTAN-NAPROXEN 85-500 MG 00378-8755-59 49.76176 EACH 2019-02-20
SUMATRIPTAN-NAPROXEN 85-500 MG 65862-0928-36 49.76176 EACH 2019-02-20
SUMATRIPTAN-NAPROXEN 85-500 MG 44183-0850-09 49.76176 EACH 2019-02-20
Drug Name NDC Price/Unit ($) Unit Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Chinese Patent Office
Cantor Fitzgerald
Moodys
Colorcon
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.